Residency · Residency · Cardiothoracic Surgery

Lobectomy: Open and Minimally Invasive Approaches

Overview

Anatomic lobectomy with mediastinal lymph node dissection is the gold standard for resectable NSCLC. The procedure involves individual ligation of the lobar artery branches, lobar vein, and lobar bronchus followed by fissure completion. Three approaches are available: posterolateral thoracotomy (open), video-assisted thoracoscopic surgery (VATS), and robotic-assisted thoracoscopic surgery (RATS). Minimally invasive approaches are now preferred when technically feasible, with equivalent oncologic outcomes.

Open Lobectomy via Thoracotomy

Positioning and Access

The patient is placed in the lateral decubitus position with a double-lumen endotracheal tube for single-lung ventilation. A posterolateral thoracotomy — muscle-sparing or standard — is performed through the 4th or 5th intercostal space. The muscle-sparing approach preserves the latissimus dorsi and serratus anterior. A self-retaining rib retractor provides wide exposure.

General Principles of Hilar Dissection

The operation requires systematic identification and individual ligation of the pulmonary artery branches to the target lobe, the pulmonary vein (superior or inferior) draining the target lobe, and the lobar bronchus. Fissure completion is performed using a stapler when fissures are incomplete, which is the most common scenario. The order of vessel and bronchus division varies by lobe and surgeon preference. The arterial branches are the most variable and dangerous structures.

Lobe-Specific Considerations

Right upper lobectomy, the most commonly performed lobectomy, begins with division of the truncus anterior (apical and anterior segmental arteries), followed by the superior pulmonary vein, identification of the posterior ascending artery in the fissure, and division of the right upper lobe bronchus with care to avoid narrowing the bronchus intermedius. Right middle lobectomy involves division of the middle lobe artery from the interlobar PA, the middle lobe vein (a branch of the superior pulmonary vein), and the middle lobe bronchus, with complete fissure dissection between the RML and both the RLL and RUL. Right lower lobectomy requires division of the inferior pulmonary vein, the superior segmental artery and then the basilar trunk, and the lower lobe bronchus, with takedown of the inferior pulmonary ligament. Left upper lobectomy is the most technically demanding because of multiple arterial branches: the apical-posterior, anterior, and lingular branches are divided individually, followed by the superior pulmonary vein and left upper lobe bronchus, with careful dissection around the pulmonary artery that lies very close to the bronchus. Left lower lobectomy involves division of the inferior pulmonary vein, the superior segmental artery and basilar trunk, and the lower lobe bronchus, with release of the inferior pulmonary ligament.

<image>Diagram of right lung hilar anatomy showing relationships of pulmonary artery branches, pulmonary veins, and bronchi for each lobe</image>

VATS Lobectomy

Technique

VATS lobectomy uses a 2-4 port technique with a 3-5 cm utility/access incision and no rib spreading. Standard port placement includes a camera port at the 7th or 8th intercostal space in the mid-axillary line, a utility incision at the 4th or 5th intercostal space in the anterior axillary line, and a posterior working port at the 7th intercostal space in the posterior axillary line. The anterior (Copenhagen) approach performs hilar dissection from anterior to posterior. The fissureless technique completes all hilar dissection before addressing the fissure, which reduces air leak. Endoscopic staplers are used for vessel and bronchial division, and the specimen is extracted through the utility incision in an endoscopic bag.

Advantages Over Open Thoracotomy

VATS lobectomy offers reduced postoperative pain and narcotic requirements, shorter chest tube duration and hospital stay (median 3-4 days versus 5-7 days), faster return to full activity and chemotherapy, reduced inflammatory cytokine response, and lower perioperative complication rates in large database studies. Lymph node harvest is equivalent or superior when performed by experienced surgeons, and long-term oncologic outcomes (5-year survival) are equivalent.

Conversion to Open

Conversion rates are 5-15% depending on surgeon experience and case complexity. Common reasons include bleeding, dense adhesions, incomplete fissure with difficult anatomy, and central tumors. The planned conversion threshold should be low because patient safety is paramount. Conversion is not a failure — it represents sound surgical judgment.

<image>VATS lobectomy port placement showing camera port, utility incision, and working port positions relative to intercostal spaces and anatomic landmarks</image>

Robotic-Assisted Lobectomy (RATS)

Technical Aspects

RATS uses the da Vinci surgical system with 3-4 robotic arms plus an assistant port. It provides 3D high-definition visualization with magnification, wristed instruments with 7 degrees of freedom, and a completely port-based approach (no utility incision during dissection). A robotic stapler is available for vessel and bronchus division.

Potential Advantages Over VATS

RATS offers superior visualization (3D, magnification, tremor filtration), more intuitive instrument manipulation especially in confined spaces, potentially easier lymph node dissection around major vessels, and may have a shorter learning curve for surgeons transitioning from open surgery.

Open vs. VATS vs. Robotic Lobectomy Comparison

Limitations

RATS has higher capital and per-case cost compared to VATS, loss of haptic feedback, longer setup and docking time, and inability to rapidly convert without undocking. Evidence of superior clinical outcomes over VATS is limited, and large randomized trials (ROMAN, RAVAL) are ongoing to compare robotic versus VATS approaches.

Lymph Node Assessment

Systematic Lymph Node Dissection

Systematic mediastinal lymph node dissection is the standard of care regardless of approach (open, VATS, or robotic). On the right side, stations 2R, 4R, 7, 8, and 9 are sampled. On the left side, stations 5, 6, 7, 8, and 9 are sampled. Station 10-11 nodes are removed en bloc with the specimen. A minimum of 3 N2 stations should be sampled, including station 7 (subcarinal).

Lymph Node Sampling vs. Dissection

Dissection provides more accurate staging and may have therapeutic benefit. The ACOSOG Z0030 trial showed no survival difference, but dissection ensures adequate staging. NCCN and most thoracic surgical societies recommend systematic dissection.

<image>Intraoperative view during VATS lobectomy showing endoscopic stapler dividing a pulmonary artery branch with the lobar bronchus visible posteriorly</image>

Perioperative Management

Preoperative

Key preoperative measures include smoking cessation (minimum 2-4 weeks, ideally 8 weeks preoperatively), pulmonary prehabilitation for marginal candidates, DVT prophylaxis protocol, and appropriate antibiotics within 1 hour of incision.

Intraoperative

Single-lung ventilation is achieved with a double-lumen ETT or bronchial blocker. Protective ventilation strategies are employed for the dependent lung. The bronchial stump is tested for air leak by submerging it underwater and ventilating. One to two chest tubes are placed depending on the approach.

Postoperative

Enhanced recovery after surgery (ERAS) protocols reduce complications and length of stay. Early mobilization (day of surgery or postoperative day 1) is encouraged. Aggressive pulmonary toilet with incentive spirometry and cough assistance is essential. Pain management is multimodal (intercostal nerve blocks, paravertebral blocks, epidural for open cases) while avoiding excessive opioids. Chest tubes are removed when output is less than 200-400 mL per day, there is no air leak, and the lung is fully expanded. Typical discharge is postoperative day 2-4 for VATS and postoperative day 4-7 for open.

Complications

Air leak is the most common complication (10-15%); it is considered prolonged if lasting more than 5 days, and a Heimlich valve can be considered for outpatient management. Atrial fibrillation occurs in 10-20% and is more common in elderly patients and after right-sided resections. Pneumonia occurs in 2-5% and is increased with prolonged ventilation and poor pulmonary toilet. Bronchopleural fistula is rare but devastating (less than 1% after lobectomy), presenting with sudden air leak, fever, and empyema. Chylothorax is rare and results from thoracic duct injury, especially with subcarinal or right lower mediastinal dissection. Pulmonary embolism necessitates DVT prophylaxis. Lobar torsion is rare, most commonly involving the middle lobe after upper lobectomy, and requires urgent reoperation.

Clinical Pearls

The fissureless technique (dividing the bronchus and vessels before completing the fissure) significantly reduces prolonged air leak. In VATS lobectomy, if bleeding is encountered, the first step is to apply pressure with a sponge — not to panic or blindly clamp. The pulmonary artery should always be identified before dividing anything, and the "tunnel" between the PA and the bronchus is a key landmark. Test-clamping the pulmonary vein before division ensures the correct vein is being taken (especially important for the middle lobe vein). A bronchial stump longer than one cartilage ring increases the risk of bronchopleural fistula. Robotic and VATS approaches should achieve the same oncologic operation as open surgery — lymph node dissection should never be compromised for a smaller incision.

References

• Yan TD et al. "Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of VATS lobectomy for early-stage NSCLC." J Clin Oncol. 2009.
• Falcoz PE et al. "Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer." Lancet Oncol. 2016.
• Cerfolio RJ et al. "Robotic lobectomy: long-term outcomes." Ann Thorac Surg. 2018.
• Lim E et al. "Guidelines on the radical management of patients with lung cancer." Thorax. 2010.
• NCCN Clinical Practice Guidelines: Non-Small Cell Lung Cancer. Version 2024.

Read this lecture as Markdown